Raymond James Maintains Outperform on Cullen/Frost Bankers, Lowers Price Target to $145
Raymond James analyst Michael Rose maintains Cullen/Frost Bankers (NYSE:CFR) with a Outperform and lowers the price target from $160 to $145.
Avicanna Exports Its CBD Derma-Cosmetics Brand Pura H&W Into The European Union
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) has completed its first commercial export of its evidence-based derma-cosmetic line Pura H&W into the European market as a part of its supply and distribution agreement with Bio-Gate AG.
Citigroup Maintains Buy on Mirati Therapeutics, Lowers Price Target to $127
Citigroup analyst Yigal Nochomovitz maintains Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $208 to $127.
MKM Partners Maintains Buy on Mattel, Lowers Price Target to $30
MKM Partners analyst Eric Handler maintains Mattel (NASDAQ:MAT) with a Buy and lowers the price target from $34 to $30.
MKM Partners Maintains Buy on Hasbro, Lowers Price Target to $105
MKM Partners analyst Eric Handler maintains Hasbro (NASDAQ:HAS) with a Buy and lowers the price target from $118 to $105.
Citigroup Maintains Buy on Warner Bros.Discovery, Lowers Price Target to $29
Citigroup analyst Jason Bazinet maintains Warner Bros.Discovery (NASDAQ:WBD) with a Buy and lowers the price target from $40 to $29.
Inspira Technologies Signs Agreement With Glo-Med Networks To Potentially Provide $59M For Deployment Of 3,889 HYLA Blood Sensors
Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, following
Citigroup Maintains Buy on Walt Disney, Lowers Price Target to $145
Citigroup analyst Jason Bazinet maintains Walt Disney (NYSE:DIS) with a Buy and lowers the price target from $165 to $145.
Dogness Announces Retail Distribution Partnership With Xiuhu
Dogness Continues to Build Momentum in its Largest Revenue Markets
DONGGUAN, China, July 7, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company")
Raymond James Upgrades First Mid Bancshares to Outperform, Announces $45 Price Target
Raymond James analyst Daniel Tamayo upgrades First Mid Bancshares (NASDAQ:FMBH) from Market Perform to Outperform and announces $45 price target.